董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David J. Rosa | 男 | Chief Executive Officer and Director | 59 | 2099.75万美元 | 43.91 | 2026-04-30 |
| Sreelakshmi Kolli | 女 | Independent Director | 51 | 35.71万美元 | 0.17 | 2026-04-30 |
| Joseph C. Beery | 男 | Independent Director | 63 | 35.21万美元 | 1.02 | 2026-04-30 |
| Amy L. Ladd | 女 | Independent Director | 68 | 35.46万美元 | 0.07 | 2026-04-30 |
| Monica P. Reed | 女 | Independent Director | 63 | 35.96万美元 | 0.72 | 2026-04-30 |
| Gary S. Guthart | 男 | Director and Executive Chair of the Board | 60 | 1809.49万美元 | 151.22 | 2026-04-30 |
| Jami Dover Nachtsheim | 女 | Independent Director | 67 | 35.96万美元 | 2.11 | 2026-04-30 |
| Lewis Chew | 男 | Independent Director | 63 | 36.96万美元 | 0.08 | 2026-04-30 |
| Craig H. Barratt | 男 | Lead Independent Director | 64 | 46.54万美元 | 4.79 | 2026-04-30 |
| Keith R. Leonard, Jr. | 男 | Independent Director | 64 | 35.71万美元 | 1.02 | 2026-04-30 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David J. Rosa | 男 | Chief Executive Officer and Director | 59 | 2099.75万美元 | 43.91 | 2026-04-30 |
| Henry L. Charlton | 男 | Chief Commercial and Marketing Officer and Executive Vice President | 56 | 624.07万美元 | 3.76 | 2026-04-30 |
| Gary H. Loeb | 男 | Chief Legal and Compliance Officer and Executive Vice President | 56 | 559.02万美元 | 1.80 | 2026-04-30 |
| Mark P. Brosius | 男 | Chief Manufacturing and Supply Chain Officer and Executive Vice President | 59 | 553.94万美元 | 7.55 | 2026-04-30 |
| Patricia L. Wadors | 女 | Chief Human Resources Officer and Senior Vice President | 61 | 未披露 | 未持股 | 2026-04-30 |
| Iman Jeddi | 女 | General Manager, da Vinci Platforms and Product Operations and Senior Vice President | 46 | 未披露 | 未持股 | 2026-04-30 |
| Jamie E. Samath | 男 | Chief Financial Officer and Enterprise Technology Leader and Executive Vice President | 55 | 839.60万美元 | 2.63 | 2026-04-30 |
董事简历
中英对照 |  中文 |  英文- David J. Rosa
-
David J. Rosa,他1996年3月加入Intuitive Surgical,在工程,临床开发,市场营销和产品开发中担任领导职位。2011年,罗莎先生被提升为Emerging Procedures & Technology的高级副总裁的位置,最近到了科学事务部门高级副总裁的位置。加入Intuitive Surgical之前,罗莎先生为Acuson公司横穿食道传感器的发展做出了贡献。罗莎先生以优等成绩从圣路易斯奥比斯波加州理工大学毕业获得了M.S.M.E.。他还拥有斯坦福大学的M.S.M.E.。
David J. Rosa,joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing, and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures & Technology, and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr. Rosa was promoted to the position of Executive Vice President and Chief Scientific Officer. In June 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In January 2019, Mr. Rosa took on additional responsibility as Executive Vice President and Chief Business Officer. In January 2022, Mr. Rosa transitioned to Chief Strategy and Growth Officer. In May 2023, Mr. Rosa was promoted to the role of President of the Company. Mr. Rosa also currently serves on the Board of Directors of Kardium Inc. Mr. Rosa graduated magna cum laude with a B.S. in Mechanical Engineering from California Polytechnic University at San Luis Obispo. He also holds a Master of Science in Mechanical Engineering from Stanford University. - David J. Rosa,他1996年3月加入Intuitive Surgical,在工程,临床开发,市场营销和产品开发中担任领导职位。2011年,罗莎先生被提升为Emerging Procedures & Technology的高级副总裁的位置,最近到了科学事务部门高级副总裁的位置。加入Intuitive Surgical之前,罗莎先生为Acuson公司横穿食道传感器的发展做出了贡献。罗莎先生以优等成绩从圣路易斯奥比斯波加州理工大学毕业获得了M.S.M.E.。他还拥有斯坦福大学的M.S.M.E.。
- David J. Rosa,joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing, and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures & Technology, and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr. Rosa was promoted to the position of Executive Vice President and Chief Scientific Officer. In June 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In January 2019, Mr. Rosa took on additional responsibility as Executive Vice President and Chief Business Officer. In January 2022, Mr. Rosa transitioned to Chief Strategy and Growth Officer. In May 2023, Mr. Rosa was promoted to the role of President of the Company. Mr. Rosa also currently serves on the Board of Directors of Kardium Inc. Mr. Rosa graduated magna cum laude with a B.S. in Mechanical Engineering from California Polytechnic University at San Luis Obispo. He also holds a Master of Science in Mechanical Engineering from Stanford University.
- Sreelakshmi Kolli
-
Sreelakshmi Kolli,自2023年10月起担任直觉外科公司董事会成员。她目前是全球医疗器械公司Align Technology, Inc.(“Align”)的首席数字官。Kolli女士于2003年6月加入Align,在其任职期间担任过越来越多的职务,负责领导面向客户的应用程序的业务运营和工程。2012年12月晋升为信息技术副总裁,2018年2月晋升为全球信息技术高级副总裁,2020年4月晋升为高级副总裁、首席数字官。Kolli女士还是齐默巴奥米特控股公司的董事会成员。她是Salesforce.com执行顾问委员会的成员,也是旧金山大学信息技术董事会的外部顾问。Kolli女士在印度Trichy的Bharathidasan大学获得了物理学学士学位,并在国立理工学院获得了计算机应用硕士学位。她也是加州斯坦福商学院提供的斯坦福高管项目的毕业生。
Sreelakshmi Kolli,has been a member of Intuitive Surgical, Inc. Board of Directors since October 2023. She is currently chief digital officer of Align Technology, Inc. ("Align"), a global medical device company. Ms. Kolli joined Align in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure. She was promoted to vice president, information technology, in December 2012, to senior vice president, global information technology, in February 2018, and to senior vice president, chief digital officer, in April 2020. Ms. Kolli is also a member of the Board of Directors of Zimmer Biomet Holdings, Inc. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco. Ms. Kolli earned a B.S. in physics at Bharathidasan University and an M.S. in computer applications at the National Institute of Technology, both in Trichy, India. She is also a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California. - Sreelakshmi Kolli,自2023年10月起担任直觉外科公司董事会成员。她目前是全球医疗器械公司Align Technology, Inc.(“Align”)的首席数字官。Kolli女士于2003年6月加入Align,在其任职期间担任过越来越多的职务,负责领导面向客户的应用程序的业务运营和工程。2012年12月晋升为信息技术副总裁,2018年2月晋升为全球信息技术高级副总裁,2020年4月晋升为高级副总裁、首席数字官。Kolli女士还是齐默巴奥米特控股公司的董事会成员。她是Salesforce.com执行顾问委员会的成员,也是旧金山大学信息技术董事会的外部顾问。Kolli女士在印度Trichy的Bharathidasan大学获得了物理学学士学位,并在国立理工学院获得了计算机应用硕士学位。她也是加州斯坦福商学院提供的斯坦福高管项目的毕业生。
- Sreelakshmi Kolli,has been a member of Intuitive Surgical, Inc. Board of Directors since October 2023. She is currently chief digital officer of Align Technology, Inc. ("Align"), a global medical device company. Ms. Kolli joined Align in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure. She was promoted to vice president, information technology, in December 2012, to senior vice president, global information technology, in February 2018, and to senior vice president, chief digital officer, in April 2020. Ms. Kolli is also a member of the Board of Directors of Zimmer Biomet Holdings, Inc. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco. Ms. Kolli earned a B.S. in physics at Bharathidasan University and an M.S. in computer applications at the National Institute of Technology, both in Trichy, India. She is also a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.
- Joseph C. Beery
-
Joseph C. Beery,自2020年4月起成为直觉外科公司董事会成员。Beery先生是一位经验丰富的企业信息技术(“IT”)系统领导者,在为全球公司管理IT和电子商务服务方面有着悠久的历史。Beery先生目前是LunaDNA的首席执行官,这是一家技术提供商,为研究和行业支持以患者为中心的研究和试验。Beery先生于2014年1月通过收购生物技术公司生命科学加入生命科学公司Thermo Fisher Scientific Inc.,并在2019年9月之前最后一次担任高级副总裁兼首席信息官。Beery先生此前曾于2008年至2014年担任生命科学的高级副总裁兼首席信息官,并于1999年至2008年担任美国航空公司和美国西部航空公司的高级副总裁兼首席信息官。Beery先生还担任多家私营公司和非营利组织的董事会成员。Beery先生在新墨西哥大学获得工商管理和商业计算机系统学士学位。
Joseph C. Beery,has been a member of Intuitive Surgical, Inc. Board since April 2020. Mr. Beery is an experienced leader of corporate information technology ("IT") systems with a long history in managing IT and eCommerce services for global companies. Mr. Beery is currently the Chief Executive Officer of LunaDNA, a technology provider that supports patient-focused studies and trials for research and industry. Mr. Beery joined Thermo Fisher Scientific Inc., a life sciences company, in January 2014, through its acquisition of Life Technologies Corporation, a biotechnology company, and last held the role of Senior Vice President and Chief Information Officer until September 2019. Mr. Beery previously was the Senior Vice President and Chief Information Officer at Life Technologies Corporation from 2008 to 2014 and U.S. Airways and America West Airlines from 1999 to 2008. Mr. Beery also serves as a member of the Board of Directors of several private companies and not-for-profit organizations. Mr. Beery received his B.S. in Business Administration and Business Computer Systems from the University of New Mexico. - Joseph C. Beery,自2020年4月起成为直觉外科公司董事会成员。Beery先生是一位经验丰富的企业信息技术(“IT”)系统领导者,在为全球公司管理IT和电子商务服务方面有着悠久的历史。Beery先生目前是LunaDNA的首席执行官,这是一家技术提供商,为研究和行业支持以患者为中心的研究和试验。Beery先生于2014年1月通过收购生物技术公司生命科学加入生命科学公司Thermo Fisher Scientific Inc.,并在2019年9月之前最后一次担任高级副总裁兼首席信息官。Beery先生此前曾于2008年至2014年担任生命科学的高级副总裁兼首席信息官,并于1999年至2008年担任美国航空公司和美国西部航空公司的高级副总裁兼首席信息官。Beery先生还担任多家私营公司和非营利组织的董事会成员。Beery先生在新墨西哥大学获得工商管理和商业计算机系统学士学位。
- Joseph C. Beery,has been a member of Intuitive Surgical, Inc. Board since April 2020. Mr. Beery is an experienced leader of corporate information technology ("IT") systems with a long history in managing IT and eCommerce services for global companies. Mr. Beery is currently the Chief Executive Officer of LunaDNA, a technology provider that supports patient-focused studies and trials for research and industry. Mr. Beery joined Thermo Fisher Scientific Inc., a life sciences company, in January 2014, through its acquisition of Life Technologies Corporation, a biotechnology company, and last held the role of Senior Vice President and Chief Information Officer until September 2019. Mr. Beery previously was the Senior Vice President and Chief Information Officer at Life Technologies Corporation from 2008 to 2014 and U.S. Airways and America West Airlines from 1999 to 2008. Mr. Beery also serves as a member of the Board of Directors of several private companies and not-for-profit organizations. Mr. Beery received his B.S. in Business Administration and Business Computer Systems from the University of New Mexico.
- Amy L. Ladd
-
Amy L. Ladd,自2019年8月起成为直觉外科公司董事会成员。拉德博士花了三十年时间在斯坦福大学从事骨科手术。Ladd博士自2017年12月起担任Elsbach-Richards外科教授,自2003年起在斯坦福环球医学中心担任骨科外科教授和医学教授(免疫学和风湿病学)。拉德博士自2013年9月以来一直担任佩里倡议的董事会成员。Ladd博士还曾于2018年3月至2019年3月担任美国骨科外科医生学会(AAOS)专科学会理事会主席,此前曾于2016年3月至2019年3月担任AAOS理事会成员。拉德博士是骨关节外科医师协会的副主席。Ladd博士于2022年8月被任命为生物技术公司Allakos,Inc.的董事会成员。拉德博士目前还担任多个非营利组织和一家私营公司的董事会成员。Ladd博士在SUNY北部医科大学获得医学博士学位,在罗切斯特大学完成了骨科住院治疗,并获得了哈佛大学手部联合手术奖学金。拉德博士在1990年加入斯坦福大学教师之前是法国巴黎L'Institut de la Main学院的研究员。她在达特茅斯学院获得了历史学学士学位。
Amy L. Ladd,has been a member of Intuitive Surgical, Inc. Board since August 2019. Dr. Ladd has spent three decades practicing orthopaedic surgery at Stanford University. Dr. Ladd has served as the Elsbach-Richards Professor of Surgery since December 2017 and as Professor of Orthopaedic Surgery as well as Professor of Medicine (Immunology & Rheumatology), by courtesy, at the Stanford Universal Medical Center since 2003. Dr. Ladd has served on the Board of the Perry Initiative since September 2013. Dr. Ladd also served as the chair of the American Academy of Orthopaedic Surgeons (AAOS) Board of Specialties Society from March 2018 to March 2019 and previously served as a member of the Board of the AAOS from March 2016 to March 2019. Dr. Ladd is vice president of the Association of Bone and Joint Surgeons. Dr. Ladd was appointed to serve on the Board of Directors of Allakos, Inc., a biotechnology company, in August 2022. Dr. Ladd also currently serves on the Boards of Directors of several not-for-profit organizations and a private company. Dr. Ladd received her M.D. from SUNY Upstate Medical University, completed her Orthopaedic Residency at the University of Rochester, and completed the Harvard Combined Hand Surgery Fellowship. Dr. Ladd was a fellow at L'Institut de la Main in Paris, France prior to joining the Stanford University faculty in 1990. She earned her A.B. in History from Dartmouth College. - Amy L. Ladd,自2019年8月起成为直觉外科公司董事会成员。拉德博士花了三十年时间在斯坦福大学从事骨科手术。Ladd博士自2017年12月起担任Elsbach-Richards外科教授,自2003年起在斯坦福环球医学中心担任骨科外科教授和医学教授(免疫学和风湿病学)。拉德博士自2013年9月以来一直担任佩里倡议的董事会成员。Ladd博士还曾于2018年3月至2019年3月担任美国骨科外科医生学会(AAOS)专科学会理事会主席,此前曾于2016年3月至2019年3月担任AAOS理事会成员。拉德博士是骨关节外科医师协会的副主席。Ladd博士于2022年8月被任命为生物技术公司Allakos,Inc.的董事会成员。拉德博士目前还担任多个非营利组织和一家私营公司的董事会成员。Ladd博士在SUNY北部医科大学获得医学博士学位,在罗切斯特大学完成了骨科住院治疗,并获得了哈佛大学手部联合手术奖学金。拉德博士在1990年加入斯坦福大学教师之前是法国巴黎L'Institut de la Main学院的研究员。她在达特茅斯学院获得了历史学学士学位。
- Amy L. Ladd,has been a member of Intuitive Surgical, Inc. Board since August 2019. Dr. Ladd has spent three decades practicing orthopaedic surgery at Stanford University. Dr. Ladd has served as the Elsbach-Richards Professor of Surgery since December 2017 and as Professor of Orthopaedic Surgery as well as Professor of Medicine (Immunology & Rheumatology), by courtesy, at the Stanford Universal Medical Center since 2003. Dr. Ladd has served on the Board of the Perry Initiative since September 2013. Dr. Ladd also served as the chair of the American Academy of Orthopaedic Surgeons (AAOS) Board of Specialties Society from March 2018 to March 2019 and previously served as a member of the Board of the AAOS from March 2016 to March 2019. Dr. Ladd is vice president of the Association of Bone and Joint Surgeons. Dr. Ladd was appointed to serve on the Board of Directors of Allakos, Inc., a biotechnology company, in August 2022. Dr. Ladd also currently serves on the Boards of Directors of several not-for-profit organizations and a private company. Dr. Ladd received her M.D. from SUNY Upstate Medical University, completed her Orthopaedic Residency at the University of Rochester, and completed the Harvard Combined Hand Surgery Fellowship. Dr. Ladd was a fellow at L'Institut de la Main in Paris, France prior to joining the Stanford University faculty in 1990. She earned her A.B. in History from Dartmouth College.
- Monica P. Reed
-
Monica P. Reed自2021年4月起成为直觉外科公司董事会成员。Reed博士是推动提供顶级质量医疗保健服务的大型区域卫生系统和社区医院的经验丰富的领导者。2021年至2022年,Reed博士还曾在Isleworth Healthcare Acquisition Corp.的董事会任职。此前,Reed博士曾于2001年至2006年期间服务于非营利性医疗保健系统AdventHealth,担任首席医疗官。从2006年到2016年,Reed博士担任AdventHealth Celebration的高级执行官和首席执行官,随后担任Care Continuum高级副总裁和该公司佛罗里达州中部地区的首席学习官,直到2018年3月。Reed博士于2018年5月创立了Reed咨询集团,目前她为公司提供咨询,以满足不断变化的临床和医疗保健需求。Reed博士还担任或曾经担任其他几家私营和非营利组织的董事会成员。Reed博士在Loma Linda Universit医学院获得医学博士学位,并在怀特纪念医疗中心完成了她的妇产科住院治疗。她在牛津大学赛义德商学院获得了变革咨询和指导硕士学位。
Monica P. Reed,has been a member of Intuitive Surgical, Inc. Board since April 2021. Dr. Reed is an experienced leader of large regional health systems and community hospitals promoting the delivery of top-quality healthcare services. From 2021 to 2022, Dr. Reed also served on the Board of Isleworth Healthcare Acquisition Corp. Previously, Dr. Reed served AdventHealth, a non-profit health care system, as the Chief Medical Officer from 2001 to 2006. From 2006 to 2016, Dr. Reed was the Senior Executive Officer and CEO of AdventHealth Celebration and then served as SVP for the Care Continuum and Chief Learning Officer for the Central Florida region of the corporation until March 2018. Dr. Reed founded the Reed Consulting Group in May 2018, where she currently consults with companies to address evolving clinical and healthcare needs. Dr. Reed also serves or has served as a member of the Board of Directors of several other private and not-for-profit organizations. Dr. Reed received her M.D. from Loma Linda University, School of Medicine, and completed her Obstetrics and Gynecology Residency at the White Memorial Medical Center. She earned her M.S. in Consulting and Coaching for Change from Sad Business School at the University of Oxford. - Monica P. Reed自2021年4月起成为直觉外科公司董事会成员。Reed博士是推动提供顶级质量医疗保健服务的大型区域卫生系统和社区医院的经验丰富的领导者。2021年至2022年,Reed博士还曾在Isleworth Healthcare Acquisition Corp.的董事会任职。此前,Reed博士曾于2001年至2006年期间服务于非营利性医疗保健系统AdventHealth,担任首席医疗官。从2006年到2016年,Reed博士担任AdventHealth Celebration的高级执行官和首席执行官,随后担任Care Continuum高级副总裁和该公司佛罗里达州中部地区的首席学习官,直到2018年3月。Reed博士于2018年5月创立了Reed咨询集团,目前她为公司提供咨询,以满足不断变化的临床和医疗保健需求。Reed博士还担任或曾经担任其他几家私营和非营利组织的董事会成员。Reed博士在Loma Linda Universit医学院获得医学博士学位,并在怀特纪念医疗中心完成了她的妇产科住院治疗。她在牛津大学赛义德商学院获得了变革咨询和指导硕士学位。
- Monica P. Reed,has been a member of Intuitive Surgical, Inc. Board since April 2021. Dr. Reed is an experienced leader of large regional health systems and community hospitals promoting the delivery of top-quality healthcare services. From 2021 to 2022, Dr. Reed also served on the Board of Isleworth Healthcare Acquisition Corp. Previously, Dr. Reed served AdventHealth, a non-profit health care system, as the Chief Medical Officer from 2001 to 2006. From 2006 to 2016, Dr. Reed was the Senior Executive Officer and CEO of AdventHealth Celebration and then served as SVP for the Care Continuum and Chief Learning Officer for the Central Florida region of the corporation until March 2018. Dr. Reed founded the Reed Consulting Group in May 2018, where she currently consults with companies to address evolving clinical and healthcare needs. Dr. Reed also serves or has served as a member of the Board of Directors of several other private and not-for-profit organizations. Dr. Reed received her M.D. from Loma Linda University, School of Medicine, and completed her Obstetrics and Gynecology Residency at the White Memorial Medical Center. She earned her M.S. in Consulting and Coaching for Change from Sad Business School at the University of Oxford.
- Gary S. Guthart
-
Gary S. Guthart,他于1996年4月加入了Intuitive Surgical,2010年1月,Guthart博士被任命为首席执行官。2007年7月,他被提升为董事长。在此之前,2006年2月,Guthart博士担任首席运营官。加入Intuitive Surgical之前,Guthart博士是SRI国际斯坦福研究所核心团队的一员负责开发计算机提高外科手术技术。自2009年5月,Guthart博士担任美国昂飞公司董事会的一员,他获得了加利大学伯克利分校的工程学士学位和加州理工学院工程硕士和博士学位。
Gary S. Guthart,has been director since December 2017. Dr. Guthart is currently President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery. He joined Intuitive Surgical in April 1996 and has served as the Chief Executive Officer since January 2010. In July 2007, he was promoted to President, having assumed the role of Chief Operating Officer in February 2006. Prior to joining Intuitive Surgical, Dr. Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Dr. Guthart served as a member of the Board of Directors of Affymetrix, Inc. from May 2009 until its acquisition by Thermo Fisher Scientific Inc. in March 2016.Dr. Guthart received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology. - Gary S. Guthart,他于1996年4月加入了Intuitive Surgical,2010年1月,Guthart博士被任命为首席执行官。2007年7月,他被提升为董事长。在此之前,2006年2月,Guthart博士担任首席运营官。加入Intuitive Surgical之前,Guthart博士是SRI国际斯坦福研究所核心团队的一员负责开发计算机提高外科手术技术。自2009年5月,Guthart博士担任美国昂飞公司董事会的一员,他获得了加利大学伯克利分校的工程学士学位和加州理工学院工程硕士和博士学位。
- Gary S. Guthart,has been director since December 2017. Dr. Guthart is currently President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery. He joined Intuitive Surgical in April 1996 and has served as the Chief Executive Officer since January 2010. In July 2007, he was promoted to President, having assumed the role of Chief Operating Officer in February 2006. Prior to joining Intuitive Surgical, Dr. Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Dr. Guthart served as a member of the Board of Directors of Affymetrix, Inc. from May 2009 until its acquisition by Thermo Fisher Scientific Inc. in March 2016.Dr. Guthart received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology.
- Jami Dover Nachtsheim
-
Jami Dover Nachtsheim,自2017年4月起成为直觉外科公司董事会成员。Nachtsheim女士从1980年到2000年退休,曾在半导体公司英特尔公司担任过多个职位,最近担任销售和营销集团的公司副总裁兼全球营销总监。Nachtsheim女士从2012年2月开始担任FEI公司的董事会成员。Nachtsheim女士还于2010年3月在生命科学公司Affymetrix, Inc.的董事会任职,并于2015年1月开始担任董事长。Nachtsheim女士自2019年3月起担任生物医药产品公司Cerus Corp.的董事会成员,自2021年6月起担任生物公司Telesis Bio Inc.的董事会成员。Nachtsheim女士拥有亚利桑那州立大学商业管理学士学位。
Jami Dover Nachtsheim,has been a member of Intuitive Surgical, Inc. Board since April 2017. Ms. Nachtsheim served in a variety of positions with Intel Corporation, a semiconductor company, from 1980 until her retirement in 2000, most recently as the Corporate Vice President of the Sales and Marketing Group and Director of Worldwide Marketing. Ms. Nachtsheim served on the Board of Directors of FEI Company, a high-performance electron microscopy company, from February 2012 until its acquisition by Thermo Fisher Scientific Inc. in September 2016. Ms. Nachtsheim also served on the Board of Directors of Affymetrix, Inc., a life sciences company, from March 2010, and as Chairman starting January 2015, until its acquisition by Thermo Fisher Scientific Inc. in March 2016. Ms. Nachtsheim has served on the Board of Directors of Cerus Corp., a biomedical products company, since March 2019 and Telesis Bio Inc., a biology company, since June 2021. Ms. Nachtsheim has served as a member of the Board of Directors of several other public and private companies. Ms. Nachtsheim holds a B.S. in Business Management from Arizona State University. - Jami Dover Nachtsheim,自2017年4月起成为直觉外科公司董事会成员。Nachtsheim女士从1980年到2000年退休,曾在半导体公司英特尔公司担任过多个职位,最近担任销售和营销集团的公司副总裁兼全球营销总监。Nachtsheim女士从2012年2月开始担任FEI公司的董事会成员。Nachtsheim女士还于2010年3月在生命科学公司Affymetrix, Inc.的董事会任职,并于2015年1月开始担任董事长。Nachtsheim女士自2019年3月起担任生物医药产品公司Cerus Corp.的董事会成员,自2021年6月起担任生物公司Telesis Bio Inc.的董事会成员。Nachtsheim女士拥有亚利桑那州立大学商业管理学士学位。
- Jami Dover Nachtsheim,has been a member of Intuitive Surgical, Inc. Board since April 2017. Ms. Nachtsheim served in a variety of positions with Intel Corporation, a semiconductor company, from 1980 until her retirement in 2000, most recently as the Corporate Vice President of the Sales and Marketing Group and Director of Worldwide Marketing. Ms. Nachtsheim served on the Board of Directors of FEI Company, a high-performance electron microscopy company, from February 2012 until its acquisition by Thermo Fisher Scientific Inc. in September 2016. Ms. Nachtsheim also served on the Board of Directors of Affymetrix, Inc., a life sciences company, from March 2010, and as Chairman starting January 2015, until its acquisition by Thermo Fisher Scientific Inc. in March 2016. Ms. Nachtsheim has served on the Board of Directors of Cerus Corp., a biomedical products company, since March 2019 and Telesis Bio Inc., a biology company, since June 2021. Ms. Nachtsheim has served as a member of the Board of Directors of several other public and private companies. Ms. Nachtsheim holds a B.S. in Business Management from Arizona State University.
- Lewis Chew
-
Lewis Chew,自2021年7月起担任Arista Networks公司董事会成员。2012年6月至2021年10月,周先生担任音频、语音和成像技术公司Dolby Laboratories, Inc.的执行副总裁兼首席财务官。从2001年4月到2011年9月,Chew先生在半导体元件的设计商和制造商美国国家半导体担任高级副总裁兼首席财务官。在加入美国国家半导体之前,Chew先生是会计师事务所KPMG LLP的合伙人。自2020年3月起,周先生担任跨国计算软件公司铿腾电子科技有限公司的董事会成员,并担任审计委员会主席。自2024年4月起,周先生担任领先的手术机器人公司直觉外科公司的董事会成员和审计委员会主席。2009年9月至2019年4月,周先生担任能源控股公司太平洋煤气和电力公司的董事,并担任公共政策委员会和审计委员会的主席。Mr. Chew拥有圣克拉拉大学利维商学院会计学学士学位。
Lewis Chew served as Executive Vice President and Chief Financial Officer of Dolby Laboratories, Inc., an audio, voice and imaging technology company, from 2012 to 2021. He served as Senior Vice President of Finance and Chief Financial Officer of National Semiconductor Corporation, a designer and manufacturer of semiconductor components, from 2001 to 2011. Prior to joining National Semiconductor Corporation, Mr. Chew was a partner at KPMG LLP, an accounting firm. - Lewis Chew,自2021年7月起担任Arista Networks公司董事会成员。2012年6月至2021年10月,周先生担任音频、语音和成像技术公司Dolby Laboratories, Inc.的执行副总裁兼首席财务官。从2001年4月到2011年9月,Chew先生在半导体元件的设计商和制造商美国国家半导体担任高级副总裁兼首席财务官。在加入美国国家半导体之前,Chew先生是会计师事务所KPMG LLP的合伙人。自2020年3月起,周先生担任跨国计算软件公司铿腾电子科技有限公司的董事会成员,并担任审计委员会主席。自2024年4月起,周先生担任领先的手术机器人公司直觉外科公司的董事会成员和审计委员会主席。2009年9月至2019年4月,周先生担任能源控股公司太平洋煤气和电力公司的董事,并担任公共政策委员会和审计委员会的主席。Mr. Chew拥有圣克拉拉大学利维商学院会计学学士学位。
- Lewis Chew served as Executive Vice President and Chief Financial Officer of Dolby Laboratories, Inc., an audio, voice and imaging technology company, from 2012 to 2021. He served as Senior Vice President of Finance and Chief Financial Officer of National Semiconductor Corporation, a designer and manufacturer of semiconductor components, from 2001 to 2011. Prior to joining National Semiconductor Corporation, Mr. Chew was a partner at KPMG LLP, an accounting firm.
- Craig H. Barratt
-
Craig H. Barratt,2011年4月以来他一直是直觉外科公司董事会的成员。目前他是谷歌副总裁,一个互联网公司,2013年6月,他加入了谷歌。他此前担任高通创锐讯的总裁,高通公司的网络和连接子公司,一家移动技术公司。从2011年5月到2013年2月,他担任创锐讯通信公司总裁兼首席执行官,一家专业半导体公司,从2003年到2011年被高通收购,在2002年加入创锐讯作为副总裁之前,Barratt博士担任了ArrayComm公司的许多职位,一家专业多线路信号处理公司。Barratt博士持有博士学位和斯坦福大学理学硕士学位,以及澳大利亚悉尼大学的电气工程学士学位和的数学物理学士学位。Barratt博士是美国专利的发明者之一,领域包括无线通讯和医疗成像,他合著出版了一本关于线性控制器的设计的书籍。
Craig H. Barratt,has been a member of Intuitive Surgical, Inc. Board since April 2011 and has served as Chair of Intuitive Surgical, Inc. Board since April 2020. Dr. Barratt served as the independent lead director ("Lead Director") from April 2018 to April 2020. Dr. Barratt has also served as a member and Chair of the Board of Directors of IonQ Inc. since January 2021. Dr. Barratt has previously served as the Senior Vice President and General Manager of the Connectivity Group of Intel Corporation, a semiconductor company, since its acquisition of Barefoot Networks, Inc., a computer networking company, from July 2019 until May 2020, where he previously served as President and Chief Executive Officer from April 2017 until July 2019. He held several different roles at Google, Inc., an Internet company, from June 2013 to January 2017, including Senior Vice President, Access and Energy, and Advisor. He previously served as President of Qualcomm Atheros, the networking and connectivity subsidiary of Qualcomm Inc. ("Qualcomm"), a mobile technology company, from May 2011 to February 2013. He served as President, Chief Executive Officer and a director of Atheros Communications, Inc., a fabless semiconductor company, from 2003 until its 2011 acquisition by Qualcomm. Dr. Barratt also serves or has served as a member of the Board of Directors of several private companies. Dr. Barratt holds Ph.D. and Master of Science degrees from Stanford University, as well as a Bachelor of Engineering degree in electrical engineering and a Bachelor of Science degree in pure mathematics and physics from the University of Sydney in Australia. Dr. Barratt is a co-inventor of a number of U.S. patents in fields including wireless communications and medical imaging and has co-authored a book on linear controller design and open-source software. - Craig H. Barratt,2011年4月以来他一直是直觉外科公司董事会的成员。目前他是谷歌副总裁,一个互联网公司,2013年6月,他加入了谷歌。他此前担任高通创锐讯的总裁,高通公司的网络和连接子公司,一家移动技术公司。从2011年5月到2013年2月,他担任创锐讯通信公司总裁兼首席执行官,一家专业半导体公司,从2003年到2011年被高通收购,在2002年加入创锐讯作为副总裁之前,Barratt博士担任了ArrayComm公司的许多职位,一家专业多线路信号处理公司。Barratt博士持有博士学位和斯坦福大学理学硕士学位,以及澳大利亚悉尼大学的电气工程学士学位和的数学物理学士学位。Barratt博士是美国专利的发明者之一,领域包括无线通讯和医疗成像,他合著出版了一本关于线性控制器的设计的书籍。
- Craig H. Barratt,has been a member of Intuitive Surgical, Inc. Board since April 2011 and has served as Chair of Intuitive Surgical, Inc. Board since April 2020. Dr. Barratt served as the independent lead director ("Lead Director") from April 2018 to April 2020. Dr. Barratt has also served as a member and Chair of the Board of Directors of IonQ Inc. since January 2021. Dr. Barratt has previously served as the Senior Vice President and General Manager of the Connectivity Group of Intel Corporation, a semiconductor company, since its acquisition of Barefoot Networks, Inc., a computer networking company, from July 2019 until May 2020, where he previously served as President and Chief Executive Officer from April 2017 until July 2019. He held several different roles at Google, Inc., an Internet company, from June 2013 to January 2017, including Senior Vice President, Access and Energy, and Advisor. He previously served as President of Qualcomm Atheros, the networking and connectivity subsidiary of Qualcomm Inc. ("Qualcomm"), a mobile technology company, from May 2011 to February 2013. He served as President, Chief Executive Officer and a director of Atheros Communications, Inc., a fabless semiconductor company, from 2003 until its 2011 acquisition by Qualcomm. Dr. Barratt also serves or has served as a member of the Board of Directors of several private companies. Dr. Barratt holds Ph.D. and Master of Science degrees from Stanford University, as well as a Bachelor of Engineering degree in electrical engineering and a Bachelor of Science degree in pure mathematics and physics from the University of Sydney in Australia. Dr. Barratt is a co-inventor of a number of U.S. patents in fields including wireless communications and medical imaging and has co-authored a book on linear controller design and open-source software.
- Keith R. Leonard, Jr.
-
Keith R. Leonard, Jr.自2016年1月起担任Intuitive Surgical, Inc.董事会成员。Leonard先生在制药行业拥有20多年的经验,自2016年10月起担任生物技术公司Unity Biotechnology, Inc.董事会主席,并于2016年1月至2020年3月担任首席执行官。在此之前,Leonard先生是Kythera Biopharmaceuticals, Inc.的总裁、首席执行官和董事会成员,这是一家由他共同创立的生物制药公司,专注于发现、开发和商业化美容药物市场的药物,从2005年到2015年10月被Allergan plc收购。从1991年到2004年,Leonard先生在Amgen Inc.的多个领域工作,领导各种职能,包括工程、信息技术,并最终担任安进欧洲总经理。自2021年9月以来,Leonard先生一直担任Arcutis Biotherapeutics,Inc.的董事会成员,还有几家私营公司。Leonard先生于2014年6月至2016年6月担任Anacor Pharmaceuticals,Inc.的董事会成员,并于2016年2月至2019年12月担任Sienna Biopharmaceuticals,Inc.的董事会成员。Leonard先生在加州大学洛杉矶分校获得工程学学士学位,在马里兰大学获得历史学学士学位,在加州大学伯克利分校获得工程学硕士学位,在加州大学洛杉矶分校安德森管理学院获得工商管理硕士学位。
Keith R. Leonard, Jr.,has been a member of Intuitive Surgical, Inc. Board since January 2016. Mr. Leonard has more than 20 years of experience in the pharmaceutical industry and has served as the Chairman of the Board of Unity Biotechnology, Inc., a biotechnology company, since October 2016 and was CEO from January 2016 to March 2020. Previously, Mr. Leonard was President, Chief Executive Officer, and a member of the Board of Directors of Kythera Biopharmaceuticals, Inc., a biopharmaceutical company that he co-founded, which focused on discovering, developing, and commercializing drugs for the aesthetic medicine market, from 2005 until its acquisition by Allergan plc in October 2015. Mr. Leonard worked across numerous areas at Amgen Inc. from 1991 to 2004, leading various functions including engineering, IT, and ultimately as General Manager of Amgen Europe. Mr. Leonard has served on the Board of Directors of Arcutis Biotherapeutics, Inc. since September 2021 along with several private companies. Mr. Leonard served on the Boards of Directors of Anacor Pharmaceuticals, Inc. from June 2014 to June 2016 and Sienna Biopharmaceuticals, Inc. from February 2016 to December 2019. Mr. Leonard received a B.S. in Engineering from the University of California, Los Angeles, a B.A. in History from the University of Maryland, an M.S. in Engineering from the University of California, Berkeley, and an M.B.A. from the Anderson School of Management at the University of California, Los Angeles. - Keith R. Leonard, Jr.自2016年1月起担任Intuitive Surgical, Inc.董事会成员。Leonard先生在制药行业拥有20多年的经验,自2016年10月起担任生物技术公司Unity Biotechnology, Inc.董事会主席,并于2016年1月至2020年3月担任首席执行官。在此之前,Leonard先生是Kythera Biopharmaceuticals, Inc.的总裁、首席执行官和董事会成员,这是一家由他共同创立的生物制药公司,专注于发现、开发和商业化美容药物市场的药物,从2005年到2015年10月被Allergan plc收购。从1991年到2004年,Leonard先生在Amgen Inc.的多个领域工作,领导各种职能,包括工程、信息技术,并最终担任安进欧洲总经理。自2021年9月以来,Leonard先生一直担任Arcutis Biotherapeutics,Inc.的董事会成员,还有几家私营公司。Leonard先生于2014年6月至2016年6月担任Anacor Pharmaceuticals,Inc.的董事会成员,并于2016年2月至2019年12月担任Sienna Biopharmaceuticals,Inc.的董事会成员。Leonard先生在加州大学洛杉矶分校获得工程学学士学位,在马里兰大学获得历史学学士学位,在加州大学伯克利分校获得工程学硕士学位,在加州大学洛杉矶分校安德森管理学院获得工商管理硕士学位。
- Keith R. Leonard, Jr.,has been a member of Intuitive Surgical, Inc. Board since January 2016. Mr. Leonard has more than 20 years of experience in the pharmaceutical industry and has served as the Chairman of the Board of Unity Biotechnology, Inc., a biotechnology company, since October 2016 and was CEO from January 2016 to March 2020. Previously, Mr. Leonard was President, Chief Executive Officer, and a member of the Board of Directors of Kythera Biopharmaceuticals, Inc., a biopharmaceutical company that he co-founded, which focused on discovering, developing, and commercializing drugs for the aesthetic medicine market, from 2005 until its acquisition by Allergan plc in October 2015. Mr. Leonard worked across numerous areas at Amgen Inc. from 1991 to 2004, leading various functions including engineering, IT, and ultimately as General Manager of Amgen Europe. Mr. Leonard has served on the Board of Directors of Arcutis Biotherapeutics, Inc. since September 2021 along with several private companies. Mr. Leonard served on the Boards of Directors of Anacor Pharmaceuticals, Inc. from June 2014 to June 2016 and Sienna Biopharmaceuticals, Inc. from February 2016 to December 2019. Mr. Leonard received a B.S. in Engineering from the University of California, Los Angeles, a B.A. in History from the University of Maryland, an M.S. in Engineering from the University of California, Berkeley, and an M.B.A. from the Anderson School of Management at the University of California, Los Angeles.
高管简历
中英对照 |  中文 |  英文- David J. Rosa
David J. Rosa,他1996年3月加入Intuitive Surgical,在工程,临床开发,市场营销和产品开发中担任领导职位。2011年,罗莎先生被提升为Emerging Procedures & Technology的高级副总裁的位置,最近到了科学事务部门高级副总裁的位置。加入Intuitive Surgical之前,罗莎先生为Acuson公司横穿食道传感器的发展做出了贡献。罗莎先生以优等成绩从圣路易斯奥比斯波加州理工大学毕业获得了M.S.M.E.。他还拥有斯坦福大学的M.S.M.E.。
David J. Rosa,joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing, and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures & Technology, and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr. Rosa was promoted to the position of Executive Vice President and Chief Scientific Officer. In June 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In January 2019, Mr. Rosa took on additional responsibility as Executive Vice President and Chief Business Officer. In January 2022, Mr. Rosa transitioned to Chief Strategy and Growth Officer. In May 2023, Mr. Rosa was promoted to the role of President of the Company. Mr. Rosa also currently serves on the Board of Directors of Kardium Inc. Mr. Rosa graduated magna cum laude with a B.S. in Mechanical Engineering from California Polytechnic University at San Luis Obispo. He also holds a Master of Science in Mechanical Engineering from Stanford University.- David J. Rosa,他1996年3月加入Intuitive Surgical,在工程,临床开发,市场营销和产品开发中担任领导职位。2011年,罗莎先生被提升为Emerging Procedures & Technology的高级副总裁的位置,最近到了科学事务部门高级副总裁的位置。加入Intuitive Surgical之前,罗莎先生为Acuson公司横穿食道传感器的发展做出了贡献。罗莎先生以优等成绩从圣路易斯奥比斯波加州理工大学毕业获得了M.S.M.E.。他还拥有斯坦福大学的M.S.M.E.。
- David J. Rosa,joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing, and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures & Technology, and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr. Rosa was promoted to the position of Executive Vice President and Chief Scientific Officer. In June 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In January 2019, Mr. Rosa took on additional responsibility as Executive Vice President and Chief Business Officer. In January 2022, Mr. Rosa transitioned to Chief Strategy and Growth Officer. In May 2023, Mr. Rosa was promoted to the role of President of the Company. Mr. Rosa also currently serves on the Board of Directors of Kardium Inc. Mr. Rosa graduated magna cum laude with a B.S. in Mechanical Engineering from California Polytechnic University at San Luis Obispo. He also holds a Master of Science in Mechanical Engineering from Stanford University.
- Henry L. Charlton
Henry L. Charlton 于 2003 年 11 月加入 Intuitive,并在美国和欧洲等地担任过商业领导职务。 2015 年 1 月,查尔顿先生晋升为美国销售高级副总裁,并于 2018 年 1 月晋升为美国高级副总裁兼总经理 2019 年 1 月,查尔顿先生担任高级副总裁兼总经理, 美国和欧盟 2022 年 1 月,查尔顿先生转任高级副总裁兼首席商务官。 在加入 Intuitive 之前,Charlton 先生是 Tidal Software 的美国东部销售副总裁。 他还曾在 Securant Technologies、Legato Systems 和 U.S. Surgical Corporation 工作。 查尔顿先生获得了学士学位。 匹兹堡大学历史和英语专业。
Henry L. Charlton joined Intuitive in November 2003 and has held commercial leadership positions in the U.S. and Europe, among other locations. In January 2015, Mr. Charlton was promoted to Senior Vice President, Sales, U.S. and, in January 2018, was promoted to Senior Vice President and General Manager, U.S. In January 2019, Mr. Charlton took on additional responsibility as Senior Vice President and General Manager, U.S. and E.U. In January 2022, Mr. Charlton transitioned to Senior Vice President and Chief Commercial Officer. In May 2023, Mr. Charlton transitioned to Senior Vice President and Chief Commercial and Marketing Officer. In January 2025, Mr. Charlton was promoted to the role of Executive Vice President and Chief Commercial and Marketing Officer. Prior to joining Intuitive, Mr. Charlton was Vice President of Eastern U.S. Sales at Tidal Software. He also worked at Securant Technologies, Legato Systems, and U.S. Surgical Corporation. Mr. Charlton earned his B.A. in History and English from the University of Pittsburgh.- Henry L. Charlton 于 2003 年 11 月加入 Intuitive,并在美国和欧洲等地担任过商业领导职务。 2015 年 1 月,查尔顿先生晋升为美国销售高级副总裁,并于 2018 年 1 月晋升为美国高级副总裁兼总经理 2019 年 1 月,查尔顿先生担任高级副总裁兼总经理, 美国和欧盟 2022 年 1 月,查尔顿先生转任高级副总裁兼首席商务官。 在加入 Intuitive 之前,Charlton 先生是 Tidal Software 的美国东部销售副总裁。 他还曾在 Securant Technologies、Legato Systems 和 U.S. Surgical Corporation 工作。 查尔顿先生获得了学士学位。 匹兹堡大学历史和英语专业。
- Henry L. Charlton joined Intuitive in November 2003 and has held commercial leadership positions in the U.S. and Europe, among other locations. In January 2015, Mr. Charlton was promoted to Senior Vice President, Sales, U.S. and, in January 2018, was promoted to Senior Vice President and General Manager, U.S. In January 2019, Mr. Charlton took on additional responsibility as Senior Vice President and General Manager, U.S. and E.U. In January 2022, Mr. Charlton transitioned to Senior Vice President and Chief Commercial Officer. In May 2023, Mr. Charlton transitioned to Senior Vice President and Chief Commercial and Marketing Officer. In January 2025, Mr. Charlton was promoted to the role of Executive Vice President and Chief Commercial and Marketing Officer. Prior to joining Intuitive, Mr. Charlton was Vice President of Eastern U.S. Sales at Tidal Software. He also worked at Securant Technologies, Legato Systems, and U.S. Surgical Corporation. Mr. Charlton earned his B.A. in History and English from the University of Pittsburgh.
- Gary H. Loeb
Gary H. Loeb于2022年9月加入Intuitive,担任高级副总裁、总法律顾问和首席合规官。在加入Intuitive之前,Loeb先生曾担任多家公共和私营医疗诊断和治疗公司的总法律顾问,包括2021年7月至2022年9月的Mammoth Biosciences,2019年7月至2021年7月的Sangamo Therapeutics,以及2016年11月至2019年6月的Achaogen。在担任总法律顾问之前,Loeb在Genentech从事了11年的知识产权和诉讼工作,最近担任知识产权副总裁。在加入Genentech之前,Loeb是洛杉矶和旧金山律师事务所的助理。Loeb在斯坦福大学获得了生物科学学士学位和英语学士学位,并在哥伦比亚大学法学院获得了法学博士学位。
Gary H. Loeb joined Intuitive in September 2022 as Senior Vice President, General Counsel and Chief Compliance Officer. In January 2025, Mr. Loeb was promoted to the role of Executive Vice President and Chief Legal and Compliance Officer. Prior to joining Intuitive, Mr. Loeb served as general counsel for several public and private medical diagnostic and therapeutic firms, including Mammoth Biosciences from July 2021 to September 2022, Sangamo Therapeutics from July 2019 to July 2021, and Achaogen from November 2016 to June 2019. Prior to his roles as general counsel, Mr. Loeb spent 11 years leading intellectual property and litigation at Genentech, most recently as VP, Intellectual Property. Prior to Genentech, Mr. Loeb was an associate at law firms in Los Angeles and San Francisco. Mr. Loeb earned a B.S. in Biological Sciences and a B.A. in English from Stanford University and holds a J.D. from Columbia Law School.- Gary H. Loeb于2022年9月加入Intuitive,担任高级副总裁、总法律顾问和首席合规官。在加入Intuitive之前,Loeb先生曾担任多家公共和私营医疗诊断和治疗公司的总法律顾问,包括2021年7月至2022年9月的Mammoth Biosciences,2019年7月至2021年7月的Sangamo Therapeutics,以及2016年11月至2019年6月的Achaogen。在担任总法律顾问之前,Loeb在Genentech从事了11年的知识产权和诉讼工作,最近担任知识产权副总裁。在加入Genentech之前,Loeb是洛杉矶和旧金山律师事务所的助理。Loeb在斯坦福大学获得了生物科学学士学位和英语学士学位,并在哥伦比亚大学法学院获得了法学博士学位。
- Gary H. Loeb joined Intuitive in September 2022 as Senior Vice President, General Counsel and Chief Compliance Officer. In January 2025, Mr. Loeb was promoted to the role of Executive Vice President and Chief Legal and Compliance Officer. Prior to joining Intuitive, Mr. Loeb served as general counsel for several public and private medical diagnostic and therapeutic firms, including Mammoth Biosciences from July 2021 to September 2022, Sangamo Therapeutics from July 2019 to July 2021, and Achaogen from November 2016 to June 2019. Prior to his roles as general counsel, Mr. Loeb spent 11 years leading intellectual property and litigation at Genentech, most recently as VP, Intellectual Property. Prior to Genentech, Mr. Loeb was an associate at law firms in Los Angeles and San Francisco. Mr. Loeb earned a B.S. in Biological Sciences and a B.A. in English from Stanford University and holds a J.D. from Columbia Law School.
- Mark P. Brosius
Mark P. Brosius,2012年12月加入Intuitive,担任设备工程总监。2014年8月,Brosius先生晋升为生产仪器工程高级总监。2015年6月晋升为新品导入高级总监。2017年1月,Brosius先生晋升为运营、手术器械和配件副总裁。2020年2月,晋升为运营高级副总裁。2023年5月,Brosius先生晋升为首席制造和供应链官。在加入Intuitive之前,Brosius先生曾于2002年至2011年担任Harbor Fluid Products的总裁兼首席技术官。Brosius先生获得了斯坦福大学机械工程学士学位,并在加州大学伯克利分校完成了金融专业的研究生学习。他还拥有圣路易斯奥比斯波加州理工大学工程管理荣誉学位。
Mark P. Brosius joined Intuitive in December 2012 as Director of Equipment Engineering. In Augt 2014, Mr. Brosi was promoted to Senior Director of Production Instrument Engineering. In June 2015, he was promoted to Senior Director of New Product Introduction. In January 2017, Mr. Brosi was promoted to the position of Vice President of Operations, Surgical Instruments & Accessories. In February 2020, he was promoted to Senior Vice President of Operations. In May 2023, Mr. Brosi was promoted to Chief Manufacturing and Supply Chain Officer. Prior to joining Intuitive, Mr. Brosi was President and Chief Technical Officer of Harbor Fluid Products from 2002 to 2011. Mr. Brosi earned a B.S. in Mechanical Engineering from Stanford University and completed graduate studies in Finance at the University of California, Berkeley. He also holds an honorary degree in Engineering Management from California Polytechnic University at San Luis Obispo.- Mark P. Brosius,2012年12月加入Intuitive,担任设备工程总监。2014年8月,Brosius先生晋升为生产仪器工程高级总监。2015年6月晋升为新品导入高级总监。2017年1月,Brosius先生晋升为运营、手术器械和配件副总裁。2020年2月,晋升为运营高级副总裁。2023年5月,Brosius先生晋升为首席制造和供应链官。在加入Intuitive之前,Brosius先生曾于2002年至2011年担任Harbor Fluid Products的总裁兼首席技术官。Brosius先生获得了斯坦福大学机械工程学士学位,并在加州大学伯克利分校完成了金融专业的研究生学习。他还拥有圣路易斯奥比斯波加州理工大学工程管理荣誉学位。
- Mark P. Brosius joined Intuitive in December 2012 as Director of Equipment Engineering. In Augt 2014, Mr. Brosi was promoted to Senior Director of Production Instrument Engineering. In June 2015, he was promoted to Senior Director of New Product Introduction. In January 2017, Mr. Brosi was promoted to the position of Vice President of Operations, Surgical Instruments & Accessories. In February 2020, he was promoted to Senior Vice President of Operations. In May 2023, Mr. Brosi was promoted to Chief Manufacturing and Supply Chain Officer. Prior to joining Intuitive, Mr. Brosi was President and Chief Technical Officer of Harbor Fluid Products from 2002 to 2011. Mr. Brosi earned a B.S. in Mechanical Engineering from Stanford University and completed graduate studies in Finance at the University of California, Berkeley. He also holds an honorary degree in Engineering Management from California Polytechnic University at San Luis Obispo.
- Patricia L. Wadors
Patricia L. Wadors于2024年10月加入Intuitive,担任首席人力资源官。在加入Intuitive之前,Wadors女士于2022年4月至2024年9月在劳动力管理技术公司UKG担任首席人事官,并于2020年11月至2022年4月在施工管理软件公司Procore技术公司担任首席人事官。在担任首席人力资源官和首席人事官之前,她曾在ServiceNow、LinkedIn、缤特力和雅虎担任多个领导职务。自2022年8月以来,Wadors女士一直担任AI广告解决方案公司Moloco的董事会成员。Wadors女士还曾在2020年2月至2025年3月期间在医疗保健和福利导航公司Accolade的董事会任职,当时该公司被AI pore的医疗保健平台Transcarent收购。Wadors女士在新泽西州拉马波学院获得了Biness Administration的学士学位,主修人力资源管理。
Patricia L. Wadors joined Intuitive in October 2024 as Chief Human Resces Officer. Prior to joining Intuitive, Ms. Wadors served as Chief People Officer at UKG, a workforce management technology company, from April 2022 to September 2024, and as Chief People Officer at Procore Technologies, a construction management software company, from November 2020 to April 2022. Prior to her roles as Chief Human Resces Officer and Chief People Officer, she held multiple leadership roles at ServiceNow, LinkedIn, Plantronics, and Yahoo!. Since Augt 2022, Ms. Wadors has served on the Board of Directors of Moloco, an AI advertising solutions company. Ms. Wadors also served on the Board of Directors of Accolade, a healthcare and benefits navigation company, from February 2020 to March 2025, when it was acquired by Transcarent, an AI pored healthcare platform. Ms. Wadors earned a B.S. in Biness Administration with a concentration in Human Resces Management from Ramapo College of New Jersey.- Patricia L. Wadors于2024年10月加入Intuitive,担任首席人力资源官。在加入Intuitive之前,Wadors女士于2022年4月至2024年9月在劳动力管理技术公司UKG担任首席人事官,并于2020年11月至2022年4月在施工管理软件公司Procore技术公司担任首席人事官。在担任首席人力资源官和首席人事官之前,她曾在ServiceNow、LinkedIn、缤特力和雅虎担任多个领导职务。自2022年8月以来,Wadors女士一直担任AI广告解决方案公司Moloco的董事会成员。Wadors女士还曾在2020年2月至2025年3月期间在医疗保健和福利导航公司Accolade的董事会任职,当时该公司被AI pore的医疗保健平台Transcarent收购。Wadors女士在新泽西州拉马波学院获得了Biness Administration的学士学位,主修人力资源管理。
- Patricia L. Wadors joined Intuitive in October 2024 as Chief Human Resces Officer. Prior to joining Intuitive, Ms. Wadors served as Chief People Officer at UKG, a workforce management technology company, from April 2022 to September 2024, and as Chief People Officer at Procore Technologies, a construction management software company, from November 2020 to April 2022. Prior to her roles as Chief Human Resces Officer and Chief People Officer, she held multiple leadership roles at ServiceNow, LinkedIn, Plantronics, and Yahoo!. Since Augt 2022, Ms. Wadors has served on the Board of Directors of Moloco, an AI advertising solutions company. Ms. Wadors also served on the Board of Directors of Accolade, a healthcare and benefits navigation company, from February 2020 to March 2025, when it was acquired by Transcarent, an AI pored healthcare platform. Ms. Wadors earned a B.S. in Biness Administration with a concentration in Human Resces Management from Ramapo College of New Jersey.
- Iman Jeddi
Iman Jeddi于2013年1月加入Intuitive,担任产品质量保证总监。2015年4月,杰迪博士晋升为副总裁,产品质量保证。2017年9月,杰迪博士担任系统制造&染色工程副总裁。2021年2月,杰迪博士担任副总裁兼总经理,单港平台。2022年2月,杰迪博士晋升为高级副总裁兼单端口平台总经理。2025年5月,杰迪博士晋升为达芬奇平台&产品运营高级副总裁兼总经理。Jeddi博士在医疗器械工业领域拥有20多年的经验,其中在雅培工作了五年,在那里她担任过vario工程和运营职务。Jeddi博士在不列颠哥伦比亚大学获得机械工程学士学位,在华盛顿大学获得医学工程硕士学位,在加州大学戴维斯分校获得生物医学工程博士学位。
Iman Jeddi joined Intuitive in January 2013 as Director of Product Quality Assurance. In April 2015, Dr. Jeddi was promoted to the role of Vice President, Product Quality Assurance. In September 2017, Dr. Jeddi assumed the role of Vice President System Manufacturing & Staining Engineering. In February 2021, Dr. Jeddi assumed the role of Vice President and General Manager, Single Port Platforms. In February 2022, Dr. Jeddi was promoted to Senior Vice President & General Manager of Single Port Platforms. In May 2025, Dr. Jeddi was promoted to Senior Vice President & General Manager, da Vinci Platforms & Product Operations. Dr. Jeddi has more than 20 years of experience in the medical device indtry, including five years at Abbott Laboratories, where she held vario engineering and operations roles. Dr. Jeddi earned a B.S. in Mechanical Engineering from the University of British Columbia, an M.S. in Medical Engineering from the University of Washington, and a Ph.D. in Biomedical Engineering from the University of California, Davis.- Iman Jeddi于2013年1月加入Intuitive,担任产品质量保证总监。2015年4月,杰迪博士晋升为副总裁,产品质量保证。2017年9月,杰迪博士担任系统制造&染色工程副总裁。2021年2月,杰迪博士担任副总裁兼总经理,单港平台。2022年2月,杰迪博士晋升为高级副总裁兼单端口平台总经理。2025年5月,杰迪博士晋升为达芬奇平台&产品运营高级副总裁兼总经理。Jeddi博士在医疗器械工业领域拥有20多年的经验,其中在雅培工作了五年,在那里她担任过vario工程和运营职务。Jeddi博士在不列颠哥伦比亚大学获得机械工程学士学位,在华盛顿大学获得医学工程硕士学位,在加州大学戴维斯分校获得生物医学工程博士学位。
- Iman Jeddi joined Intuitive in January 2013 as Director of Product Quality Assurance. In April 2015, Dr. Jeddi was promoted to the role of Vice President, Product Quality Assurance. In September 2017, Dr. Jeddi assumed the role of Vice President System Manufacturing & Staining Engineering. In February 2021, Dr. Jeddi assumed the role of Vice President and General Manager, Single Port Platforms. In February 2022, Dr. Jeddi was promoted to Senior Vice President & General Manager of Single Port Platforms. In May 2025, Dr. Jeddi was promoted to Senior Vice President & General Manager, da Vinci Platforms & Product Operations. Dr. Jeddi has more than 20 years of experience in the medical device indtry, including five years at Abbott Laboratories, where she held vario engineering and operations roles. Dr. Jeddi earned a B.S. in Mechanical Engineering from the University of British Columbia, an M.S. in Medical Engineering from the University of Washington, and a Ph.D. in Biomedical Engineering from the University of California, Davis.
- Jamie E. Samath
Jamie E. Samath,2013年4月,他加入了Intuitive Surgical担任副总裁和总监。2013年10月,Samath先生被任命为首席会计长。在加入直观手术之前,从2011年10月到2013年4月,Samath先生是Atmel公司的财务副总裁和总监。从2011年12月到2013年4月,担任Atmel公司的首席会计长。加入Atmel公司之前,从1991年2月到2011年9月,Samath先生曾在美国国家半导体公司担任各种金融岗位,该公司于2011年9月被德州仪器公司收购。从2005年6月至2010年6月,Samath先生是美国国家半导体公司的首席会计长和总监,从2010年6月到2011年9月,美国国家半导体公司副总裁和首席会计长,总监。Samath先生获得了伦敦城市大学学士学位和他是注册会计师(不活跃)。
Jamie E. Samath joined Intuitive in April 2013 as Vice President and Corporate Controller. In October 2013, Mr. Samath was appointed to the position of Principal Accounting Officer. In Augt 2019, Mr. Samath was promoted to the position of Senior Vice President, Finance. In January 2022, Mr. Samath was promoted to the position of Senior Vice President, Chief Financial Officer. In July 2024, Mr. Samath transitioned to the position of Senior Vice President, Chief Financial Officer and Head of Biness Technology. In January 2025, Mr. Samath was promoted to the role of Executive Vice President, Chief Financial Officer and Enterprise Technology Leader (previoly titled Head of Biness Technology). Prior to joining Intuitive, Mr. Samath was the Vice President Finance, Corporate Controller, and Principal Accounting Officer at Atmel Corporation, a semiconductor company, and served in vario finance roles at National Semiconductor Corporation. Since April 2025, Mr. Samath has served on the Board of Directors of KLA Corporation, a capital equipment manufacturer. Mr. Samath received his B.A. in Biness Studies from London Metropolitan University and is a Certified Public Accountant (inactive).- Jamie E. Samath,2013年4月,他加入了Intuitive Surgical担任副总裁和总监。2013年10月,Samath先生被任命为首席会计长。在加入直观手术之前,从2011年10月到2013年4月,Samath先生是Atmel公司的财务副总裁和总监。从2011年12月到2013年4月,担任Atmel公司的首席会计长。加入Atmel公司之前,从1991年2月到2011年9月,Samath先生曾在美国国家半导体公司担任各种金融岗位,该公司于2011年9月被德州仪器公司收购。从2005年6月至2010年6月,Samath先生是美国国家半导体公司的首席会计长和总监,从2010年6月到2011年9月,美国国家半导体公司副总裁和首席会计长,总监。Samath先生获得了伦敦城市大学学士学位和他是注册会计师(不活跃)。
- Jamie E. Samath joined Intuitive in April 2013 as Vice President and Corporate Controller. In October 2013, Mr. Samath was appointed to the position of Principal Accounting Officer. In Augt 2019, Mr. Samath was promoted to the position of Senior Vice President, Finance. In January 2022, Mr. Samath was promoted to the position of Senior Vice President, Chief Financial Officer. In July 2024, Mr. Samath transitioned to the position of Senior Vice President, Chief Financial Officer and Head of Biness Technology. In January 2025, Mr. Samath was promoted to the role of Executive Vice President, Chief Financial Officer and Enterprise Technology Leader (previoly titled Head of Biness Technology). Prior to joining Intuitive, Mr. Samath was the Vice President Finance, Corporate Controller, and Principal Accounting Officer at Atmel Corporation, a semiconductor company, and served in vario finance roles at National Semiconductor Corporation. Since April 2025, Mr. Samath has served on the Board of Directors of KLA Corporation, a capital equipment manufacturer. Mr. Samath received his B.A. in Biness Studies from London Metropolitan University and is a Certified Public Accountant (inactive).